跳至主要内容
临床试验/CTRI/2025/02/080533
CTRI/2025/02/080533尚未招募2 期

Evaluation of comparative Clinical efficacy of Yastimadhu Rasayana versus Ashwagandha Rasayana in young adults with symptoms of Easy Mental Fatiguability-A Randomized control trial.

NA1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2025年3月6日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
NA
入组人数
110
试验地点
1
主要终点
Mental Fatigue Scores

研究概览

简要总结

The Title of the Research work: Evaluation of  comparative Clinical efficacy of Yastimadhu  Rasayana Versus Ashwagadha Rasayana in young adults with symptoms of Easy Mental-Fatiguability – A Randomized control trial.

AIM of the Study

Evaluation of  comparative clinical efficacy of Yastimadhu Rasayana Versus Ashwagandha Rasayana in young adults with symptom  of Easy mental Fatiguability.

OBJECTIVES

1.     To evaluate the efficacy of Yastimadhu Rasayana in the management of Easy mental Fatiguability on the basis of objective and subjective parameters.

2.     To evaluate the efficacy of Ashwagandha Rasayana in the management of Easy mental Fatiguability on the basis of objective and subjective parameters.

3.     To compare the efficacy of Yastimadhu Rasayana and Ashwagandha Rasayana in the management of Easy mental fatiguability on the basis of objective and subjective parameters.

Hypothesis

RESEARCH  HYPOTHESIS:

Alternate Hypothesis (H1) Yastimadhu Rasayana is not inferior in management of Easy mental Fatiguability when compared to Ashwagandha Rasayana.

Null Hypothesis (H0)

There is no difference in the efficacy of Yastimadhu Rasayana and Ashwagandha Rasayana in the management of Easy mental  Fatiguability .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 30.00 Year(s)(—)
性别
All

入选标准

  • Patients who would be ready to accept the treatment protocol guideline as per the study and would give informed consent.
  • All the patients of genders, male and female, of the age group 18 to 30 years, have socioeconomic status in the middle and upper class.
  • Patients belonging to managerial work, student, and academician as an occupation.
  • Patients with symptoms of easy mental fatiguability (Assessed with CIS-R score of more than 26).
  • Patients who are not using any kind of tonics multivitamins for improving general health.

排除标准

  • Patients who are not willing to participate in the trial.
  • Patients with Hb levels less than 13 gm% (male) and 9 gm% (female).
  • Patient with acute and chronic Metabolic, Endocrinal, and nutritional disorders.
  • Patients suffering from chronic debilitating diseases.
  • Patients with alcohol and drug abuse.
  • Patients with evidence of delirium, confusion, and other disturbances of consciousness, psychotropic diseases using any psychotropic drug.

结局指标

主要结局

Mental Fatigue Scores

时间窗: At the baseline (Day 0) and at the end of intervention (Day 61)

CFS Scores

时间窗: At the baseline (Day 0) and at the end of intervention (Day 61)

次要结局

  • MFIS Scores ( to measure the impact of mental fatigue )(FSS Scores ( to assess the severity and frequency))

研究者

发起方
NA
申办方类型
Other [na]
责任方
Principal Investigator
主要研究者

Mahima Shrivastava

Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H), Wardha,

研究点 (1)

Loading locations...

相似试验